MS

Morgan Stanley Faces Potetnial Liabilities Over Backpay

Barrons is reporting this afternoon: "Morgan Stanley advisors know that if they leave the company to join a competitor, they forfeit their deferred compensation. Now, a recent court ruling may open a legal avenue for ex-Morgan advisors to reclaim millions in deferred pay." For full coverage click here. Morgan Stanley shares are stable, and are currently trading at $93.69.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The large-cap Capital Markets company has moved 6.4% over the last year compared to 20.7% for the S&P 500 for a difference of -14.3%. The company recorded a 52 week high of $100.99 and a 52 week low of $69.42. Morgan Stanley has 81 full time employees and is based in New York, NY.

Investors rarely win by following headlines and chasing trends — unless they have a deep understanding of the fundamentals of each stock they invest in.

2018 2019 2020 2021 2022 2023
Revenue (MM) $13,892 $17,098 $10,162 $9,411 $21,595 $45,455
Revenue Growth n/a 23.08% -40.57% -7.39% 129.47% 110.49%
Interest Income (MM) $3,806 $4,694 $6,313 $8,045 $9,327 $8,652
Operating Margins 81% 66% 142% 209% 65% 28%
Net Margins 63% 53% 108% 160% 51% 22%
Net Income (MM) $8,748 $9,042 $10,996 $15,034 $11,029 $9,806
Depreciation & Amort. (MM) $1,844 $2,643 $3,769 $4,216 $3,998 $4,057
Earnings Per Share $4.73 $5.19 $6.46 $8.03 $6.15 $5.59
EPS Growth n/a 9.73% 24.47% 24.3% -23.41% -9.11%
Diluted Shares (MM) 1,738 1,640 1,624 1,814 1,713 1,643
Free Cash Flow (MM) $5,440 $38,947 -$26,675 $31,663 -$9,475 -$33,033
Capital Expenditures (MM) $1,865 $1,826 $1,444 $2,308 $3,078 $3,253
Current Ratio 1.0 1.0 1.0 1.0 1.0 1.0
Total Debt (MM) $188,117 $190,060 $213,388 $227,363 $233,867 $242,843
Net Debt / EBITDA 12.05 13.32 5.92 4.17 5.85 8.11
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS